Purpose-led, Performance-driven

DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.

Our story

DSM is positioned to drive continued above market organic growth and deliver further improvement in profitability, shareholder return and sustainability as we execute Strategy 2021.

Our performance

The Annual Results published on 13 February confirm DSM delivered a good financial performance for year and achieved the key milestones in the first year of it's Strategy 2021.

Shareholder information

We have recently celebrated the 30th anniversary of our privitisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Nutrition

We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.

Animal Nutrition & Health

2019
Sales: ↑€2,892 (2018: €2,749)
Organic Growth: ↑4%
Volume Growth: ↑2%
Price Growth: ↑2%

Human Nutrition

2019
Sales: ↑€2,046 (2018: €1,989)
Organic Growth: ↓1%
Volume Growth: ↑2%
Price Growth: ↓3%

Food Specialties

2019
Sales: ↑€572 (2018: €490)
Sales: ↑17%
Organic Growth: ↑4

Personal Care

2019
Sales: ↑€425 (2018: €382)
Sales: ↑11%
Organic Growth: ↑9%

Sales1
€6,028m

Adjusted EBITDA1
€1,250M

Adjusted EBITDA Margin1
20.7%

1) Underlying business, net of temporary vitamin effect

Materials

Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.

DSM Engineering Materials

2019
Sales: ↓€1,406 (2018: €1,516)
Organic Growth: ↓10%

DSM Protective Materials

2019
Sales: ↓€338 (2018: €344)
Organic Growth: ↓4%

DSM Resins

2019
Sales: ↓€1,002 (2018: €1,053)
Organic Growth: ↓6%

Sales
€2,746M

Adjusted EBITDA
€509M

Adjusted EBITDA Margin
18.5%

Latest financial & regulatory news

Investor contacts

Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures. 

Dave Huizing
Vice President Investor Relations
+31 45 578 2864

Anna Morello
Investor Relations Manager
+31 45 578 2282

Marc Silvertand
Investor Relations Manager
+31 45 578 2348

Daniel Uribe
Investor Relations Analyst
+31 45 578 2864

Sandra Segers
Personal Assistant
+31 45 578 2864

Petra Volk
Support Officer
+31 45 578 2511

Read more

  • At a glance

    Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.

  • Factbooks

    An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.

This site uses cookies to store information on your computer.

Learn more